Sign In
Buy PFE
$26.04
+0.345 (+1.34%)
At Close: Jun 05, 2026
Pfizer's Activist Battle Might Fizzle---but Its Stock Probably Won't
07:00am, Saturday, 26'th Oct 2024
The pharmaceutical company's stock is relatively cheap, representing an opportunity for patient value investors.
Billionaires Are Buying 4 High-Yield Dividend Blue Chips Hand Over Fist
06:16am, Saturday, 26'th Oct 2024
24/7 Wall St. Insights Big money hedge funds are buying high-yield blue chips, expecting rates to drop further.
Got $1,000? 2 Healthcare Stocks to Buy and Hold Forever.
07:00am, Friday, 25'th Oct 2024
These two stocks have moved in different directions this year, but that shouldn't mean much to long-term investors.
3 Sweet Dividend Stocks to Treat Your Portfolio With This Halloween
04:40am, Friday, 25'th Oct 2024
There are more reasons to buy these stocks besides their high payouts.
Final Trades: Pfizer, S&P Aerospace and Defense, and Live Nation
02:08pm, Thursday, 24'th Oct 2024
Today's Final Trades from the Investment Committee.
Gear Up for Pfizer (PFE) Q3 Earnings: Wall Street Estimates for Key Metrics
10:21am, Thursday, 24'th Oct 2024
Beyond analysts' top -and-bottom-line estimates for Pfizer (PFE), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter e
Pfizer Q3 Preview: Why The Stock Is A Buy Ahead Of Earnings
09:00am, Thursday, 24'th Oct 2024
Pfizer's Q3 consensus estimate is likely to be exceeded as the successful integration of Seagen assets and the deleveraging efforts should lead to stronger EPS growth in the coming quarters. In Q2, we
5 High-Yield Dividend Stocks to Buy Without Hesitation
07:45am, Thursday, 24'th Oct 2024
These five dividend powerhouses offer yields above 4%.
Advisory Committee on Immunization Practices Recommends PREVNAR 20® (20-Valent Pneumococcal Conjugate Vaccine) for Adults Aged 50 and Older
04:45pm, Wednesday, 23'rd Oct 2024
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practice (ACIP) voted to expand i
Starboard Slams Pfizer for R&D Inefficiencies, Overpaid Acquisitions
02:21pm, Wednesday, 23'rd Oct 2024
Starboard calls out PFE's board of directors to take action against the latter's management for not earning sustainable revenue returns on R&D and M&A.
PFE Gets FDA Nod for Expanded Use of RSV Vaccine Abrysvo
12:36pm, Wednesday, 23'rd Oct 2024
The FDA approves Pfizer's RSV vaccine, Abrysvo, for adults aged 18-59 years with increased risk of the disease.
Should You Buy, Sell or Hold Pfizer Stock Before Q3 Earnings?
10:50am, Wednesday, 23'rd Oct 2024
PFE's non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the third quarter.
Goldman Sachs Says Huge S&P 500 Decade Over, but It Loves 5 High-Yield Dividend Stocks
08:47am, Wednesday, 23'rd Oct 2024
24/7 Wall St. Insights The current market rally is now two years old.
The Best Pharmaceutical Stock to Invest $1,000 in Right Now
05:13am, Wednesday, 23'rd Oct 2024
Its cheap valuation, strong growth prospects, and massive dividend make it ripe for outsize investment returns.
US FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease
05:19pm, Tuesday, 22'nd Oct 2024
The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in adults aged 18 to 59 at increased risk of the dise
